Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N Maini

Showing results (331-340 of 337) with videos related to

Pageof 34
Sort By:
You have reached the last page of results.This site can display upto 337 results.
Annals of the Rheumatic Diseases|June 30, 2000
Consensus statement on the initiation and continuation of tumour necrosis factor blocking therapies in rheumatoid arthritisJ S Smolen, F C Breedveld, G R Burmester, et al.
The New England Journal of Medicine|November 30, 2000
Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study GroupP E Lipsky, D M van der Heijde, E W St Clair, et al.
Annals of the Rheumatic Diseases|July 3, 2008
Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockadeJ S Smolen, C Han, D M F M van der Heijde, et al.
Annals of the Rheumatic Diseases|December 1, 1999
Access to disease modifying treatments for rheumatoid arthritis patientsD E Furst, F C Breedveld, G R Burmester, et al.
Arthritis and Rheumatism|October 27, 1997
Range of antinuclear antibodies in "healthy" individualsE M Tan, T E Feltkamp, J S Smolen, et al.
Arthritis and Rheumatism|March 24, 1999
A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificityE M Tan, J S Smolen, J S McDougal, et al.
Annals of the Rheumatic Diseases|October 29, 2000
Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis (May 2000)D E Furst, F C Breedveld, G R Burmester, et al.
Pageof 34

Showing results (331-340 of 337) with videos related to

Sort By:
Pageof 34
You have reached the last page of results.This site can display upto 337 results.
Annals of the Rheumatic Diseases|June 30, 2000
Consensus statement on the initiation and continuation of tumour necrosis factor blocking therapies in rheumatoid arthritisJ S Smolen, F C Breedveld, G R Burmester, et al.
The New England Journal of Medicine|November 30, 2000
Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study GroupP E Lipsky, D M van der Heijde, E W St Clair, et al.
Annals of the Rheumatic Diseases|July 3, 2008
Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockadeJ S Smolen, C Han, D M F M van der Heijde, et al.
Annals of the Rheumatic Diseases|December 1, 1999
Access to disease modifying treatments for rheumatoid arthritis patientsD E Furst, F C Breedveld, G R Burmester, et al.
Arthritis and Rheumatism|October 27, 1997
Range of antinuclear antibodies in "healthy" individualsE M Tan, T E Feltkamp, J S Smolen, et al.
Arthritis and Rheumatism|March 24, 1999
A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificityE M Tan, J S Smolen, J S McDougal, et al.
Annals of the Rheumatic Diseases|October 29, 2000
Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis (May 2000)D E Furst, F C Breedveld, G R Burmester, et al.
Pageof 34